Literature DB >> 24255012

Response to "Ethnic-specific in vitro-in vivo extrapolation and physiologically based pharmacokinetic approaches to predict cytochrome P450-mediated pharmacokinetics in Chinese population: opportunities and challenges".

Zoe E Barter1, Geoffrey T Tucker, Karen Rowland-Yeo.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 24255012     DOI: 10.1007/s40262-013-0118-x

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  4 in total

1.  Ethnic-specific in vitro-in vivo extrapolation and physiologically based pharmacokinetic approaches to predict cytochrome P450-mediated pharmacokinetics in the Chinese population: opportunities and challenges.

Authors:  Guo-Fu Li; Guo Yu; Hong-Xia Liu; Qing-Shan Zheng
Journal:  Clin Pharmacokinet       Date:  2014-02       Impact factor: 6.447

2.  Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation.

Authors:  I Johansson; M Oscarson; Q Y Yue; L Bertilsson; F Sjöqvist; M Ingelman-Sundberg
Journal:  Mol Pharmacol       Date:  1994-09       Impact factor: 4.436

3.  Molecular basis of genetic variation in debrisoquin hydroxylation in Chinese subjects: polymorphism in RFLP and DNA sequence of CYP2D6.

Authors:  S L Wang; J D Huang; M D Lai; B H Liu; M L Lai
Journal:  Clin Pharmacol Ther       Date:  1993-04       Impact factor: 6.875

4.  Differences in cytochrome p450-mediated pharmacokinetics between chinese and caucasian populations predicted by mechanistic physiologically based pharmacokinetic modelling.

Authors:  Zoe E Barter; Geoffrey T Tucker; Karen Rowland-Yeo
Journal:  Clin Pharmacokinet       Date:  2013-12       Impact factor: 6.447

  4 in total
  3 in total

1.  Evaluating a physiologically based pharmacokinetic model for prediction of omeprazole clearance and assessing ethnic sensitivity in CYP2C19 metabolic pathway.

Authors:  Sheng Feng; Yumi Cleary; Neil Parrott; Pei Hu; Cornelia Weber; Yongqing Wang; Ophelia Q P Yin; Jun Shi
Journal:  Eur J Clin Pharmacol       Date:  2015-03-24       Impact factor: 2.953

2.  Impact of Ethnicity-Specific Hepatic Microsomal Scaling Factor, Liver Weight, and Cytochrome P450 (CYP) 1A2 Content on Physiologically Based Prediction of CYP1A2-Mediated Pharmacokinetics in Young and Elderly Chinese Adults.

Authors:  Guo-Fu Li; Qing-Shan Zheng; Yichao Yu; Wei Zhong; Hong-Hao Zhou; Furong Qiu; Guangji Wang; Guo Yu; Hartmut Derendorf
Journal:  Clin Pharmacokinet       Date:  2019-07       Impact factor: 6.447

Review 3.  IVIVE: Facilitating the Use of In Vitro Toxicity Data in Risk Assessment and Decision Making.

Authors:  Xiaoqing Chang; Yu-Mei Tan; David G Allen; Shannon Bell; Paul C Brown; Lauren Browning; Patricia Ceger; Jeffery Gearhart; Pertti J Hakkinen; Shruti V Kabadi; Nicole C Kleinstreuer; Annie Lumen; Joanna Matheson; Alicia Paini; Heather A Pangburn; Elijah J Petersen; Emily N Reinke; Alexandre J S Ribeiro; Nisha Sipes; Lisa M Sweeney; John F Wambaugh; Ronald Wange; Barbara A Wetmore; Moiz Mumtaz
Journal:  Toxics       Date:  2022-05-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.